Literature DB >> 28741682

Strengthening the laboratory diagnosis of pathogenic Corynebacterium species in the Vaccine era.

S K Rajamani Sekar1, B Veeraraghavan1, S Anandan1, N K Devanga Ragupathi1, L Sangal2, S Joshi2.   

Abstract

Over the last three decades, successful implementation of the diphtheria vaccination in the developed and developing countries has reduced the infections caused by the toxigenic strains of Corynebacterium diphtheriae, but a concomitant increase in the invasive infections due to the nontoxigenic strains was seen. In addition, the recent reports on the emergence of nontoxigenic toxin gene-bearing strains, having the potential to revert back to toxigenic form poses a significant threat to human beings. Besides infections caused by C. diphtheriae, the emergence of the respiratory, cutaneous and invasive infections by related pathogenic Corynebacterium species like C. ulcerans and C. pseudotuberculosis, complicate the diagnosis and management of infection. These observations together with the widespread prevalence of diphtheria in the vaccine era, necessitates the strengthening of the epidemiological surveillance and laboratory diagnosis of the pathogen. This review provides the overview of the advantages and limitations of different molecular methods and the role of MALDI-TOF in the laboratory diagnosis of Diphtheria. The contribution of next generation sequencing technology and different genotyping techniques in understanding the pathogenicity, transmission dynamics and epidemiology of the C. diphtheriae is discussed.
© 2017 The Society for Applied Microbiology.

Entities:  

Keywords:  MLST; diphtheria; laboratory diagnosis; molecular assays; nontoxigenic

Mesh:

Substances:

Year:  2017        PMID: 28741682     DOI: 10.1111/lam.12781

Source DB:  PubMed          Journal:  Lett Appl Microbiol        ISSN: 0266-8254            Impact factor:   2.858


  1 in total

1.  The Brief Case: Nontoxigenic Corynebacterium diphtheriae in a Nonhealing Wound.

Authors:  Olivia Kates; Kimberly Starr; Lori Bourassa
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.